These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 1178768)

  • 1. In vitro release of noramidopyrine methansulfonate sodium from suppository as a function of particle size and concentration.
    Kassem AA; Nour El-Din E; Abd El-Bary A; Fadel HM
    Pharmazie; 1975 Jul; 30(7):475-6. PubMed ID: 1178768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colorimetric-thin-layer-chromatographic estimation of noramidopyrine methansulfonate sodium in dosage forms.
    Diab AM; Awad NS
    Pharmazie; 1975 Nov; 30(11):745-6. PubMed ID: 1219779
    [No Abstract]   [Full Text] [Related]  

  • 3. Colorimetric assay of noramidopyrine methanesulfonate sodium in formulations and in blood and urine samples.
    Diab AH
    Pharmazie; 1977 Apr; 32(4):226-7. PubMed ID: 896911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physical parameters of chlorphenamine maleate suppositories and its release as a function of particle size, concentration and nature of the base.
    el-Din EN; Mursi NM; Elbary AA; Foda N
    Pharmazie; 1977; 32(8-9):515-7. PubMed ID: 594118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of PMR spectrometry in pharmaceutical analysis.
    El-Fatatry HM
    Pharmazie; 1983 Apr; 38(4):227-8. PubMed ID: 6867084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Changes in physiochemical properties of shelved oleaginous suppository bases: the effects on indomethacin, aminopyrine and sulpyrine release rates].
    Ejima A; Tatsuzawa M; Ogata H; Aoyagi N; Kaniwa N; Matsuda R
    Eisei Shikenjo Hokoku; 1983; (101):75-9. PubMed ID: 6675777
    [No Abstract]   [Full Text] [Related]  

  • 7. In vitro release of chloramphenicol from different suppository bases.
    Kassem AA; Nour El-Din E; Abd El-Bary A; Fadel HM
    Pharmazie; 1975 Jul; 30(7):472-5. PubMed ID: 1178767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feasibility of the Ph.Eur. flow-through cell for dissolution testing of the compounded rectal suppositories containing indomethacin or sodium diclofenac.
    Woyczikowski B; Szulc J; Sznitowska M; Janicki S; Pilichowski J; Urbańska A
    Acta Pol Pharm; 2003; 60(3):169-72. PubMed ID: 14556483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of temperature on drug release and drug absorption in mixed type diclofenac sodium suppositories].
    Iwata M; Takayama K; Takahashi Y; Obata Y; Machida Y; Nagai T; Shirotake S
    Yakugaku Zasshi; 1999 Feb; 119(2):170-7. PubMed ID: 10067431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spectrophotometric determination of papaverine in some pharmaceutical preparations containing noramidopyrine methansulfonate sodium.
    Moussa AF
    Pharmazie; 1978 Jul; 33(7):460-1. PubMed ID: 724767
    [No Abstract]   [Full Text] [Related]  

  • 11. In vitro release of meclozine hydrochloride from lipophilic suppository bases with or without tensides.
    Bećirević M; Petricić V; Kallay N
    Pharmazie; 1984 Dec; 39(12):828-30. PubMed ID: 6531391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Biopharmaceutical study of aminophenazone-containing suppositories. 2. Results of in vitro drug release and in vivo drug absorption].
    Tantó M; Ecsy Z; Selmeczi B; Regdon G
    Acta Pharm Hung; 1990 Jul; 60(4):149-55. PubMed ID: 2239342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Biopharmaceutical study of aminophenazone-containing suppositories. 1. Experimental materials and methods, determination of physical qualities of the suppositories].
    Tantó M; Ecsy Z; Selmeczi B; Regdon G
    Acta Pharm Hung; 1990 Jul; 60(4):143-8. PubMed ID: 2239341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparison of in vitro model examinaitons with respect to drug release from suppositories].
    Regdon G; Vágó I; Mándi E; Regdon G; Erós I
    Acta Pharm Hung; 2000 Apr; 70(2):45-51. PubMed ID: 11192740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The release of naproxen in fatty suppository bases by beta-cyclodextrin complexation.
    Celebi N; Iscanoglu M; Degim T
    Pharmazie; 1991 Dec; 46(12):863-5. PubMed ID: 1818322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reciprocating dialysis tube method: periodic tapping improved in vitro release/dissolution testing of suppositories.
    Itoh S; Teraoka N; Matsuda T; Okamoto K; Takagi T; Oo C; Danny Kao H
    Eur J Pharm Biopharm; 2006 Nov; 64(3):393-8. PubMed ID: 16890412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Blood level kinetics of sodium noramidopyrine methanesulfonate (Analgin) in late pregnancy].
    Peiker G; Müller B; Voigt G; Nöschel H
    Pharmazie; 1983 Jun; 38(6):406-8. PubMed ID: 6611643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Interference of noramidopyrin and its derivatives on the dosage of uric acid].
    Giudicelli Y; Kaiser JM; Pecquery R; Remy JM
    Ann Biol Clin (Paris); 1975; 33(2):115-9. PubMed ID: 1180417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Experiences with the rectal use of a chemotherapeutic agent. 1. In vitro biopharmaceutical examinations; selection of the optimal vehicle].
    Regdon G; Erös I; Gombkötö Z; Németh J; Regdon G; Vernyik A; Sallai J
    Acta Pharm Hung; 1998 Jul; 68(4):224-8. PubMed ID: 9737023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced release of diazepam from hollow-type suppositories.
    Kaewnopparat N; Kaewnopparat S; Rojanarat W; Ingkatawornwong S
    Int J Pharm Compd; 2004; 8(4):310-2. PubMed ID: 23924703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.